Expression of SLC24A3 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

SLC24A3 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 6.78

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

11.1

Number of samples

141

Samples

Sample	Description	TPM
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	52.0
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	51.7
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	42.0
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	40.4
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	29.4
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	28.8
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	28.8
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	27.8
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	27.5
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	27.5
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	26.5
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	25.6
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	24.8
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	23.6
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	23.3
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	23.3
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	23.0
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	22.8
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	22.0
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	22.0
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	21.8
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	21.2
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	21.1
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	20.4
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	19.5
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	19.4
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	18.2
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	17.3
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	17.3
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	17.3
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	16.8
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	16.1
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	15.9
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	15.7
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	15.3
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	14.6
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	14.4
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	14.0
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	13.9
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	13.8
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	13.7
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	13.5
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	13.4
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	13.1
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	13.1
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	12.8
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	12.7
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	12.7
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	12.7
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	12.5
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	11.7
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	11.6
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	11.2
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	11.2
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	11.1
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	11.0
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	11.0
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	10.8
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	10.5
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	10.4
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	10.3
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	9.8
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	9.6
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	9.5
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	9.5
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	9.2
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	8.9
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	8.7
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	8.6
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	8.5
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	8.2
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	8.0
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	7.9
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	7.8
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	7.7
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	7.6
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	7.3
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	7.3
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	7.0
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	7.0
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	6.8
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	6.8
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	6.8
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	6.7
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	6.7
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	6.6
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	6.4
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	6.4
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	6.1
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	6.1
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	5.8
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	5.7
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	5.7
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	5.6
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	5.5
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	5.5
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	5.0
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	5.0
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	5.0
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	4.8
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	4.7
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	4.5
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	4.5
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	4.3
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	4.3
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	3.9
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	3.9
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	3.8
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	3.7
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	3.6
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	3.6
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	3.5
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	3.4
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	3.4
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	3.4
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	3.4
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	3.3
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	3.2
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	3.2
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	3.2
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	3.1
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	3.0
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	2.9
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	2.9
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	2.8
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	2.5
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	2.4
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	2.3
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	2.0
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	1.9
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	1.8
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	1.5
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	1.5
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	1.5
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	1.2
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	1.1
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	1.0
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	0.5
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	0.3
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	0.3
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	0.1
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

SLC24A3 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 4.23

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

5.3

Number of samples

Samples

Sample	Description	TPM
AK226	N, NA, stage:NA, dead, 360 days	20.0
AK088	N, NA, stage:NA, dead, 360 days	19.6
AK053	N, NA, stage:NA, dead, 300 days	16.8
AK035	N, NA, stage:NA, dead, 210 days	15.8
AK123	N, NA, stage:NA, dead, 180 days	13.8
AK098	N, NA, stage:NA, dead, 660 days	10.6
AK213	N, NA, stage:NA, alive, 2010 days	10.0
AK158	N, NA, stage:NA, dead, 360 days	9.0
AK100	N, NA, stage:NA, alive, 960 days	8.7
AK076	N, NA, stage:NA, alive, 660 days	8.6
AK134	N, NA, stage:NA, dead, 360 days	8.5
AK102	N, NA, stage:NA, alive, 1740 days	8.1
AK074	N, NA, stage:NA, alive, 300 days	8.1
AK081	N, NA, stage:NA, dead, 180 days	8.0
AK133	N, NA, stage:NA, dead, 360 days	7.6
AK066	N, NA, stage:NA, alive, 960 days	7.1
AK199	N, NA, stage:NA, alive, 1860 days	6.2
AK124	N, NA, stage:NA, alive, 1920 days	6.1
AK085	N, NA, stage:NA, alive, 660 days	5.9
AK002	N, NA, stage:NA, dead, 570 days	5.7
AK183	N, NA, stage:NA, alive, 360 days	5.3
AK068	N, NA, stage:NA, alive, 360 days	5.2
AK165	N, NA, stage:NA, alive, 360 days	5.0
AK117	N, NA, stage:NA, dead, 210 days	4.7
AK006	N, NA, stage:NA, dead, 360 days	4.6
AK103	N, NA, stage:NA, alive, 1320 days	4.3
AK079	N, NA, stage:NA, dead, 210 days	4.2
AK072	N, NA, stage:NA, dead, 150 days	4.1
AK015	N, NA, stage:NA, alive, 720 days	4.0
AK089	N, NA, stage:NA, dead, 330 days	3.9
AK167	N, NA, stage:NA, dead, 180 days	3.9
AK099	N, NA, stage:NA, dead, 420 days	3.9
AK041	N, NA, stage:NA, alive, 810 days	3.8
AK051	N, NA, stage:NA, dead, 360 days	3.7
AK173	N, NA, stage:NA, dead, 180 days	3.4
AK003	N, NA, stage:NA, dead, 600 days	3.2
AK030	N, NA, stage:NA, dead, 120 days	3.2
AK049	N, NA, stage:NA, dead, 180 days	3.2
AK149	N, NA, stage:NA, dead, 420 days	2.8
AK091	N, NA, stage:NA, dead, 210 days	2.8
AK043	N, NA, stage:NA, alive, 660 days	2.6
AK218	N, NA, stage:NA, dead, 180 days	2.5
AK071	N, NA, stage:NA, dead, 540 days	2.5
AK142	N, NA, stage:NA, alive, 90 days	2.4
AK188	N, NA, stage:NA, alive, 420 days	2.0
AK195	N, NA, stage:NA, dead, 390 days	1.9
AK236	N, NA, stage:NA, dead, 360 days	1.9
AK005	N, NA, stage:NA, dead, 240 days	1.8
AK216	N, NA, stage:NA, dead, 360 days	1.6
AK231	N, NA, stage:NA, dead, 240 days	1.5
AK055	N, NA, stage:NA, dead, 240 days	1.1
AK156	N, NA, stage:NA, dead, 330 days	1.0
AK185	N, NA, stage:NA, alive, 330 days	1.0
AK178	N, NA, stage:NA, dead, 240 days	0.9
AK227	N, NA, stage:NA, alive, 300 days	0.8
AK139	N, NA, stage:NA, dead, 270 days	0.6
AK153	N, NA, stage:NA, dead, 240 days	0.4
AK205	N, NA, stage:NA, dead, 120 days	0.1
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0206330003	Tumor	N/A
CPT0186100003	Tumor	N/A
CPT0123530003	Tumor	N/A
CPT0201710003	Tumor	N/A
CPT0216920008	Tumor	N/A
CPT0218890004	Tumor	N/A
CPT0224390004	Tumor	N/A
CPT0204390003	Normal	N/A
CPT0093590003	Tumor	N/A
CPT0167750004	Tumor	N/A
CPT0204400003	Normal	N/A
CPT0079790003	Tumor	N/A
CPT0218690004	Tumor	N/A
CPT0204370003	Normal	N/A
CPT0161730003	Tumor	N/A
CPT0168720003	Tumor	N/A
CPT0206880003	Tumor	N/A
CPT0189650004	Tumor	N/A
CPT0204350003	Normal	N/A
CPT0168380003	Tumor	N/A
CPT0205890003	Tumor	N/A
CPT0217880003	Tumor	N/A
CPT0206560003	Tumor	N/A
CPT0087680003	Tumor	N/A
CPT0206000004	Tumor	N/A
CPT0218670003	Tumor	N/A
CPT0204340003	Normal	N/A
CPT0189850004	Tumor	N/A
CPT0224330003	Tumor	N/A
CPT0218330004	Tumor	N/A
CPT0167640003	Tumor	N/A
CPT0002410011	Tumor	N/A
CPT0093450003	Tumor	N/A
CPT0206110003	Tumor	N/A
CPT0217430008	Tumor	N/A
CPT0217000004	Tumor	N/A
CPT0196850003	Tumor	N/A
CPT0189250003	Tumor	N/A
CPT0189570004	Tumor	N/A
CPT0162020003	Tumor	N/A
CPT0167530003	Tumor	N/A
CPT0207030003	Tumor	N/A
CPT0127420003	Tumor	N/A
CPT0205670004	Tumor	N/A
CPT0208980003	Tumor	N/A
CPT0206780003	Tumor	N/A
CPT0182500003	Tumor	N/A
CPT0217710008	Tumor	N/A
CPT0168830003	Tumor	N/A
CPT0182550003	Tumor	N/A
CPT0189460003	Tumor	N/A
CPT0167860004	Tumor	N/A
CPT0125220003	Tumor	N/A
CPT0171580008	Tumor	N/A
CPT0087730003	Tumor	N/A
CPT0104330003	Tumor	N/A
CPT0168590003	Tumor	N/A
CPT0205450004	Tumor	N/A
CPT0219080004	Tumor	N/A
CPT0087570003	Tumor	N/A
CPT0162140003	Tumor	N/A
CPT0175060003	Tumor	N/A
CPT0205780003	Tumor	N/A
CPT0218960004	Tumor	N/A
CPT0064650003	Tumor	N/A
CPT0125570003	Tumor	N/A
CPT0190360004	Tumor	N/A
CPT0206670004	Tumor	N/A
CPT0204380003	Normal	N/A
CPT0092440003	Tumor	N/A
CPT0162100003	Tumor	N/A
CPT0221180003	Tumor	N/A
CPT0225760003	Tumor	N/A
CPT0093510003	Tumor	N/A
CPT0190240004	Tumor	N/A
CPT0228220003	Tumor	N/A
CPT0204410003	Normal	N/A
CPT0224540004	Tumor	N/A
CPT0209440003	Tumor	N/A
CPT0089150003	Tumor	N/A
CPT0204360003	Normal	N/A
CPT0168080003	Tumor	N/A
CPT0078580003	Tumor	N/A
CPT0127480003	Tumor	N/A
CPT0204420003	Normal	N/A
CPT0218830004	Tumor	N/A
CPT0225730003	Tumor	N/A
CPT0093360003	Tumor	N/A
CPT0168270003	Tumor	N/A
CPT0206450003	Tumor	N/A
CPT0207090003	Tumor	N/A
CPT0104220003	Tumor	N/A
CPT0224600003	Tumor	N/A
CPT0087950003	Tumor	N/A
CPT0204330003	Normal	N/A
CPT0199770003	Tumor	N/A
CPT0205570003	Tumor	N/A
CPT0093550003	Tumor	N/A
CPT0167970003	Tumor	N/A
CPT0182580003	Tumor	N/A
CPT0168480003	Tumor	N/A
CPT0206230003	Tumor	N/A
CPT0189750004	Tumor	N/A
CPT0217100003	Tumor	N/A
CPT0064890003	Tumor	N/A
CPT0217190003	Tumor	N/A
CPT0218770003	Tumor	N/A
CPT0125510003	Tumor	N/A
CPT0217060003	Tumor	N/A
CPT0071100003	Tumor	N/A
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA043400	Antibody HPA045497
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade